Is Sabra Healthcare Stock a Good Investment?
Sabra Healthcare Investment Advice | SBRA |
- Examine Sabra Healthcare's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Sabra Healthcare's leadership team and their track record. Good management can help Sabra Healthcare navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Diversified REITs space and any emerging trends that could impact Sabra Healthcare's business and its evolving consumer preferences.
- Compare Sabra Healthcare's performance and market position to its competitors. Analyze how Sabra Healthcare is positioned in terms of product offerings, innovation, and market share.
- Check if Sabra Healthcare pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Sabra Healthcare's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Sabra Healthcare REIT stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Sabra Healthcare REIT is a good investment.
Sell | Buy |
Sell
Market Performance | Insignificant | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Examine Sabra Healthcare Stock
Researching Sabra Healthcare's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 99.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.5. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Sabra Healthcare REIT last dividend was issued on the 14th of February 2025. The entity had 1:3 split on the 16th of November 2010.
To determine if Sabra Healthcare is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Sabra Healthcare's research are outlined below:
| Sabra Healthcare REIT currently holds 1.76 B in liabilities with Debt to Equity (D/E) ratio of 0.76, which is about average as compared to similar companies. Sabra Healthcare REIT has a current ratio of 0.76, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Sabra Healthcare's use of debt, we should always consider it together with its cash and equity. | |
| Over 99.0% of Sabra Healthcare shares are owned by institutional investors | |
| Latest headline from gurufocus.com: Sabra Health Care REIT Inc Announces Leadership Transition |
Sabra Healthcare Quarterly Cash And Short Term Investments |
|
Sabra Healthcare uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Sabra Healthcare REIT. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Sabra Healthcare's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 20th of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 20th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Sabra Healthcare's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Sabra Healthcare's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-08-07 | 2023-06-30 | 0.1 | 0.09 | -0.01 | 10 | ||
2011-11-02 | 2011-09-30 | 0.08 | 0.07 | -0.01 | 12 | ||
2011-08-02 | 2011-06-30 | 0.09 | 0.08 | -0.01 | 11 | ||
2020-11-05 | 2020-09-30 | 0.16 | 0.18 | 0.02 | 12 | ||
2011-05-04 | 2011-03-31 | 0.07 | 0.05 | -0.02 | 28 | ||
2024-10-31 | 2024-09-30 | 0.16 | 0.13 | -0.03 | 18 | ||
2024-05-08 | 2024-03-31 | 0.14 | 0.11 | -0.03 | 21 | ||
2020-05-06 | 2020-03-31 | 0.21 | 0.17 | -0.04 | 19 |
Sabra Healthcare Target Price Consensus
Sabra target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Sabra Healthcare's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 14 | Strong Buy |
Most Sabra analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Sabra stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Sabra Healthcare REIT, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationSabra Healthcare Target Price Projection
Sabra Healthcare's current and average target prices are 17.17 and 19.83, respectively. The current price of Sabra Healthcare is the price at which Sabra Healthcare REIT is currently trading. On the other hand, Sabra Healthcare's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Sabra Healthcare Market Quote on 25th of March 2025
Target Price
Analyst Consensus On Sabra Healthcare Target Price
Sabra Healthcare Analyst Ratings
Sabra Healthcare's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Sabra Healthcare stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Sabra Healthcare's financials, market performance, and future outlook by experienced professionals. Sabra Healthcare's historical ratings below, therefore, can serve as a valuable tool for investors.Know Sabra Healthcare's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Sabra Healthcare is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sabra Healthcare REIT backward and forwards among themselves. Sabra Healthcare's institutional investor refers to the entity that pools money to purchase Sabra Healthcare's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Hhg Plc | 2024-12-31 | 3.5 M | Nuveen Asset Management, Llc | 2024-12-31 | 3.4 M | Dimensional Fund Advisors, Inc. | 2024-12-31 | 3.3 M | Wellington Management Company Llp | 2024-12-31 | 3.2 M | Norges Bank | 2024-12-31 | 2.8 M | Amvescap Plc. | 2024-12-31 | 2.6 M | Duff & Phelps Inv Mgmt Co (il) | 2024-12-31 | 2.5 M | Goldman Sachs Group Inc | 2024-12-31 | 2.5 M | Systematic Financial Management Lp | 2024-12-31 | 2.4 M | Blackrock Inc | 2024-12-31 | 37 M | Vanguard Group Inc | 2024-12-31 | 35 M |
Sabra Healthcare's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.13 B.Market Cap |
|
Sabra Healthcare's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.02 | 0.02 | |
| Return On Capital Employed | 0.04 | 0.05 | |
| Return On Assets | 0.02 | 0.02 | |
| Return On Equity | 0.05 | 0.04 |
Determining Sabra Healthcare's profitability involves analyzing its financial statements and using various financial metrics to determine if Sabra Healthcare is a good buy. For example, gross profit margin measures Sabra Healthcare's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Sabra Healthcare's profitability and make more informed investment decisions.
Please note, the presentation of Sabra Healthcare's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Sabra Healthcare's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Sabra Healthcare's management manipulating its earnings.
Evaluate Sabra Healthcare's management efficiency
Sabra Healthcare REIT has return on total asset (ROA) of 0.03 % which means that it generated a profit of $0.03 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0457 %, meaning that it created $0.0457 on every $100 dollars invested by stockholders. Sabra Healthcare's management efficiency ratios could be used to measure how well Sabra Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Capital Employed is expected to grow to 0.05, whereas Return On Tangible Assets are forecasted to decline to 0.02. At present, Sabra Healthcare's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 6.2 M, whereas Total Assets are forecasted to decline to about 4.3 B.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 11.74 | 12.25 | |
| Tangible Book Value Per Share | 11.62 | 12.02 | |
| Enterprise Value Over EBITDA | 13.93 | 13.23 | |
| Price Book Value Ratio | 1.48 | 1.53 | |
| Enterprise Value Multiple | 13.93 | 13.23 | |
| Price Fair Value | 1.48 | 1.53 | |
| Enterprise Value | 5.7 B | 3.3 B |
The strategic initiatives led by Sabra Healthcare's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Basic technical analysis of Sabra Stock
As of the 25th of March, Sabra Healthcare has the Semi Deviation of 1.91, risk adjusted performance of 0.0258, and Coefficient Of Variation of 4275.19. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sabra Healthcare REIT, as well as the relationship between them.Sabra Healthcare's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Sabra Healthcare insiders, such as employees or executives, is commonly permitted as long as it does not rely on Sabra Healthcare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Sabra Healthcare insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Sabra Healthcare's Outstanding Corporate Bonds
Sabra Healthcare issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Sabra Healthcare REIT uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Sabra bonds can be classified according to their maturity, which is the date when Sabra Healthcare REIT has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| SBRA 32 01 DEC 31 Corp BondUS78574MAA18 | View | |
| US78572XAG60 Corp BondUS78572XAG60 | View | |
| SABHLD 1125 15 DEC 27 Corp BondUS78573NAH52 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Understand Sabra Healthcare's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Sabra Healthcare's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0258 | |||
| Market Risk Adjusted Performance | 0.0807 | |||
| Mean Deviation | 1.35 | |||
| Semi Deviation | 1.91 | |||
| Downside Deviation | 1.95 | |||
| Coefficient Of Variation | 4275.19 | |||
| Standard Deviation | 1.71 | |||
| Variance | 2.93 | |||
| Information Ratio | 0.0389 | |||
| Jensen Alpha | 0.0456 | |||
| Total Risk Alpha | 0.0993 | |||
| Sortino Ratio | 0.0341 | |||
| Treynor Ratio | 0.0707 | |||
| Maximum Drawdown | 6.66 | |||
| Value At Risk | (3.05) | |||
| Potential Upside | 2.61 | |||
| Downside Variance | 3.82 | |||
| Semi Variance | 3.65 | |||
| Expected Short fall | (1.28) | |||
| Skewness | (0.46) | |||
| Kurtosis | (0.03) |
| Risk Adjusted Performance | 0.0258 | |||
| Market Risk Adjusted Performance | 0.0807 | |||
| Mean Deviation | 1.35 | |||
| Semi Deviation | 1.91 | |||
| Downside Deviation | 1.95 | |||
| Coefficient Of Variation | 4275.19 | |||
| Standard Deviation | 1.71 | |||
| Variance | 2.93 | |||
| Information Ratio | 0.0389 | |||
| Jensen Alpha | 0.0456 | |||
| Total Risk Alpha | 0.0993 | |||
| Sortino Ratio | 0.0341 | |||
| Treynor Ratio | 0.0707 | |||
| Maximum Drawdown | 6.66 | |||
| Value At Risk | (3.05) | |||
| Potential Upside | 2.61 | |||
| Downside Variance | 3.82 | |||
| Semi Variance | 3.65 | |||
| Expected Short fall | (1.28) | |||
| Skewness | (0.46) | |||
| Kurtosis | (0.03) |
Consider Sabra Healthcare's intraday indicators
Sabra Healthcare intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Sabra Healthcare stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 40268.81 | |||
| Daily Balance Of Power | (0.53) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 17.24 | |||
| Day Typical Price | 17.22 | |||
| Price Action Indicator | (0.16) | |||
| Period Momentum Indicator | (0.18) |
Sabra Healthcare Corporate Filings
8K | 24th of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 4th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 5th of February 2025 Other Reports | ViewVerify | |
13A | 18th of October 2024 An amended filing to the original Schedule 13G | ViewVerify |
Sabra Stock media impact
Far too much social signal, news, headlines, and media speculation about Sabra Healthcare that are available to investors today. That information is available publicly through Sabra media outlets and privately through word of mouth or via Sabra internal channels. However, regardless of the origin, that massive amount of Sabra data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Sabra Healthcare news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Sabra Healthcare relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Sabra Healthcare's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Sabra Healthcare alpha.
Sabra Healthcare Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Sabra Healthcare can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Sabra Healthcare REIT Historical Investor Sentiment
Investor biases related to Sabra Healthcare's public news can be used to forecast risks associated with an investment in Sabra. The trend in average sentiment can be used to explain how an investor holding Sabra can time the market purely based on public headlines and social activities around Sabra Healthcare REIT. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Sabra Healthcare's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Sabra Healthcare and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Sabra Healthcare news discussions. The higher the estimate score, the more favorable the investor's outlook on Sabra Healthcare.
Sabra Healthcare Corporate Management
| Peter Nyland | Executive Management | Profile | |
| Michael Costa | CFO VP | Profile | |
| Eliza Gozar | Senior Investments | Profile | |
| Kara Pappanduros | Senior Management | Profile | |
| Darrin Smith | Executive Investments | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sabra Healthcare REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sabra Healthcare. If investors know Sabra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sabra Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.827 | Dividend Share 1.2 | Earnings Share 0.54 | Revenue Per Share | Quarterly Revenue Growth 0.125 |
The market value of Sabra Healthcare REIT is measured differently than its book value, which is the value of Sabra that is recorded on the company's balance sheet. Investors also form their own opinion of Sabra Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Sabra Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sabra Healthcare's market value can be influenced by many factors that don't directly affect Sabra Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Sabra Healthcare's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Sabra Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sabra Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.